Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naltrexone”

392 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 392 results

Very early researchLooking for participantsNCT05007561
What this trial is testing

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

Who this might be right for
NaltrexonePlacebo
San Diego State University 210
Post-approval studies (Phase 4)Looking for participantsNCT06620562
What this trial is testing

Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet

Who this might be right for
Obesity; DrugObesity, Morbid
Laval University 108
Large-scale testing (Phase 3)Study completedNCT00501696
What this trial is testing

Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Who this might be right for
Multiple Sclerosis
University of California, San Francisco 80
Testing effectiveness (Phase 2)UnknownNCT04738773
What this trial is testing

RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response

Who this might be right for
Eye TrackingGambling DisorderNaltrexone
University of Sao Paulo 40
Testing effectiveness (Phase 2)Study completedNCT01449565
What this trial is testing

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)

Who this might be right for
Amphetamine-Related Disorders
San Francisco Department of Public Health 100
Early research (Phase 1)Study completedNCT05304364
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)

Who this might be right for
Opiod Use Disorder
Delpor, Inc. 10
Large-scale testing (Phase 3)Ended earlyNCT00269607
What this trial is testing

Naltrexone Implants as Relapse Prevention

Who this might be right for
Opioid Dependency
University of Oslo 12
Testing effectiveness (Phase 2)Study completedNCT00000307
What this trial is testing

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

Who this might be right for
Alcohol-Related DisordersCocaine-Related Disorders
National Institute on Drug Abuse (NIDA)
Testing effectiveness (Phase 2)Looking for participantsNCT05955313
What this trial is testing

Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Who this might be right for
VulvodyniaNaltrexoneQuality of Life
Medical University of Lublin 300
Testing effectiveness (Phase 2)Study completedNCT00302133
What this trial is testing

Optimizing Pharmacotherapy for Bipolar Alcoholics

Who this might be right for
Bipolar DisorderAlcohol Dependence
University of Miami 88
Testing effectiveness (Phase 2)Ended earlyNCT04480554
What this trial is testing

Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

Who this might be right for
Opioid-use DisorderHIV-1-infectionImmune Activation+5 more
University of Pennsylvania 78
Post-approval studies (Phase 4)Study completedNCT05569031
What this trial is testing

Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse

Who this might be right for
Opiate Withdrawal Syndrome
Zagazig University 52
Large-scale testing (Phase 3)Study completedNCT00501631
What this trial is testing

ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence

Who this might be right for
Alcohol Dependence
Alkermes, Inc. 300
Not applicableNot Yet RecruitingNCT07641283
What this trial is testing

Naltrexone for Nonsuicidal Self-Injury

Who this might be right for
Nonsuicidal Self-InjurySelf-Injurious Behavior
Seoul National University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00715117
What this trial is testing

The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease

Who this might be right for
Crohn's Disease
Milton S. Hershey Medical Center 14
Early research (Phase 1)Study completedNCT03879460
What this trial is testing

The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations

Who this might be right for
Opioid Intoxication
Timothy Smith 15
Testing effectiveness (Phase 2)WithdrawnNCT00398008
What this trial is testing

HIV Risk Reduction and Drug Abuse Treatment in Iran

Who this might be right for
Opiate DependenceHIV Infections
Yale University
Not applicableStudy completedNCT03581630
What this trial is testing

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Who this might be right for
Breast CancerObesityOverweight
Gangnam Severance Hospital 72
Large-scale testing (Phase 3)Ended earlyNCT03970330
What this trial is testing

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

Who this might be right for
Endometriosis
Milton S. Hershey Medical Center 9
Early research (Phase 1)Study completedNCT01999114
What this trial is testing

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

Who this might be right for
ECG Effects
Purdue Pharma LP 328
Load More Results